All Stocks

Data may be delayed.

SOPL - Sopan Pharmaceuticals Limited | NEPSE Analytics

SOPL

Manufacturing And Processing

Sopan Pharmaceuticals Limited

Rs. 808.50

+105.40 (+14.99%)

Circuit: 632.79 – 773.41Circuit Hit

MA:

Oscillators:

Levels:

Key Statistics

As of 17 Jun 2026

Open Price

745.80

Close Price

808.50

Prev Close

703.10

High / Low

808.50 / 745.80

52-Wk High / Low

808.50 / 276.50

Total Traded Qty

740

Avg Volume

468

Turnover

Rs. 5.96 Lakh

Market Cap

Rs. 13.87 Arba

Listed Shares

17,160,000

Paid Up Value

—

Instrument Type

Equity

Fundamentals

EPS

0.00

P/E Ratio

0.00

Book Value

100.00

P/B Ratio

7.03

ROE

—

Net Profit

—

Revenue

—

Fiscal Year

082-083 Q2

Stock Assessment

Trades at a P/E discount to its sector with positive EPS momentum and consistent dividend history. RSI in neutral territory. Technical and fundamental signals balanced with moderate supporting factors.

Supporting

+ Strong ROE of 18.2%

+ P/E discount to sector

Caution

- RSI approaching overbought

Sign in to see the Assessment for SOPL

Fundamental Analysis

P/E Ratio15.20 (sector: 18.5)

EPS Growth+12.5%

ROE18.2%

Technical Analysis

RSI (14)52.3

MACDBullish

Risk Score

4/10

Signal

BUY

Sign in to see full Analysis for SOPL

Data as of 17 Jun 2026